Wernicke encephalopathy prevention and treatment — Rapid

Synopsis

Prevent thiamine-deficiency brain injury, recognise the incomplete and easily missed Wernicke presentation, and deliver current UK oral, intramuscular or intravenous thiamine regimens with magnesium, nutrition and refeeding safety.

Wernicke encephalopathy is a clinical diagnosis caused by inadequate thiamine availability; normal imaging or the absence of the complete triad does not exclude it.
Think beyond alcohol withdrawal: risk includes poor diet, low BMI, weight loss, vomiting, decompensated liver disease, memory difficulty, neuropathy and prior complicated withdrawal.
Current national lower-risk prophylaxis for harmful or dependent drinkers is oral thiamine 50 mg four times daily, including during medically assisted withdrawal.
High-risk community prophylaxis is intramuscular thiamine 200–300 mg once daily for at least 3 days with daily review, then oral thiamine; use an inpatient route if IM is unsuitable.
High-risk hospital prophylaxis is intramuscular or intravenous thiamine 200–300 mg once daily for 3–5 days with daily review, followed by oral thiamine.
Suspected or established disease requires intravenous thiamine 300–500 mg three times daily for 3–5 days, not oral treatment alone.
If still symptomatic after the initial course, give 300–500 mg intravenously once daily for another 3–5 days and thereafter while improvement continues, while looking for another cause.
Check and replace magnesium because deficiency can prevent thiamine activation; provide parenteral treatment where anaphylaxis can be recognised and treated.

Key red flags

Any new confusion, impaired attention or memory disturbance in a malnourished person with harmful or dependent drinking should trigger immediate Wernicke consideration.

Ophthalmoplegia, nystagmus, gaze palsy or new unsteady gait is sufficient to escalate even when confusion is subtle or absent.

Hypothermia, hypotension, coma or rapidly reduced consciousness may be an atypical severe presentation and requires broad emergency assessment.

Persistent symptoms despite thiamine should prompt magnesium re-check and investigation for sepsis, head injury, hepatic encephalopathy, intoxication and other neurological disease.

Very low body mass, negligible intake, major weight loss or electrolyte depletion signals simultaneous refeeding-syndrome risk when nutrition restarts.

Investigation priorities

Immediate clinical assessmentFirst step

Identify neurological signs and nutritional risk without delaying treatment for a laboratory result.

Management branches

PreventionStratify nutritional risk

A person drinks harmfully or dependently, whether or not withdrawal is planned.

Ask about diet, weight loss, BMI, memory, neuropathy, liver disease, prior complicated withdrawal and acute illness.
Give oral thiamine 50 mg four times daily to the lower-risk group; use parenteral prophylaxis for any high-risk pattern.
Review intake and recovery, continuing oral thiamine after injections until holistic nutritional and alcohol recovery review supports stopping.

Key medicines

Thiamine prophylaxisLower-risk harmful or dependent drinking: thiamine 50 mg orally four times daily. High-risk community care: thiamine 200–300 mg intramuscularly once daily for at least 3 days with daily review. High-risk hospital care: 200–300 mg intramuscularly or intravenously once daily for 3–5 days; follow every parenteral course with oral thiamine.Oral absorption may be negligible in malnutrition or dependence, so do not use oral therapy alone for high risk or suspected disease. Give injections through trained services; use hospital intravenous treatment when IM tissue, bleeding risk or clinical status makes community injection unsuitable.

Thiamine for suspected Wernicke encephalopathyGive thiamine 300–500 mg intravenously three times daily for 3–5 days with daily review. If symptoms remain after 5 days, give 300–500 mg intravenously once daily for a further 3–5 days and then for as long as clinical improvement continues; follow with oral thiamine.Administer where anaphylaxis can be treated, but do not let the very small reaction risk delay an emergency regimen. Check and correct magnesium, assess refeeding risk, and seek another cause when symptoms persist.

Open full textbook →Answer 2 questions